Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Bacteriology

Evaluation of Pyrrolidonyl Arylamidase Activity in Staphylococcus delphini

Samantha T. Compton, Stephen A. Kania, Amy E. Robertson, Sara D. Lawhon, Stephen G. Jenkins, Lars F. Westblade, David A. Bemis
Karen C. Carroll, Editor
Samantha T. Compton
aDepartment of Biomedical and Diagnostic Sciences, University of Tennessee College of Veterinary Medicine, Knoxville, Tennessee, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen A. Kania
aDepartment of Biomedical and Diagnostic Sciences, University of Tennessee College of Veterinary Medicine, Knoxville, Tennessee, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amy E. Robertson
bNewYork–Presbyterian/Weill Cornell Medical Center, New York, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sara D. Lawhon
cDepartment of Veterinary Pathobiology, Texas A&M University College of Veterinary Medicine, College Station, Texas, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sara D. Lawhon
Stephen G. Jenkins
dDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lars F. Westblade
dDepartment of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David A. Bemis
aDepartment of Biomedical and Diagnostic Sciences, University of Tennessee College of Veterinary Medicine, Knoxville, Tennessee, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen C. Carroll
The Johns Hopkins University School of Medicine
Roles: Editor
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.02076-16
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Clinical reference textbooks lack data for pyrrolidonyl arylamidase (PYR) activity in Staphylococcus delphini. This study evaluated PYR activities of 21 S. delphini strains by reference broth, rapid disc, and rapid slide methods. Species and subgroup identifications were confirmed by nucleic acid-based methods and included nine group A and 12 group B strains. Testing by rapid PYR methods with products from four manufacturers was performed at two testing locations, and, with the exception of one strain tested at one location using reagents from one manufacturer, each S. delphini strain tested positive for PYR activity. Therefore, PYR may be a useful single-test adjunct for distinguishing Staphylococcus aureus from S. delphini and other members of the Staphylococcus intermedius group.

INTRODUCTION

Pyrrolidonyl arylamidase (PYR), also known as pyrrolidonyl aminopeptidase, is a bacterial enzyme that hydrolyzes l-pyroglutamic acid-β-naphthylamide to produce β-naphthylamine, which combines with N,N-dimethylaminocinnamaldehyde reagent to form a red color (1). Rapid disc or slide tests for PYR activity are used to differentiate Enterococcus species from Streptococcus species (1) but can also be used to presumptively differentiate Staphylococcus aureus from phenotypically similar staphylococci (2, 3). One such group of staphylococci is the Staphylococcus intermedius group (SIG), which includes the species Staphylococcus delphini, Staphylococcus intermedius, and Staphylococcus pseudintermedius (4). S. delphini has been further subdivided into two distinct phylogenetic clades referred to as groups A and B (5). PYR test results were not provided in the original description of S. delphini (6); however, a subsequent report indicated that 100% of 22 S. delphini isolates (17 group A and 5 group B) were PYR positive according to a commercial multibiochemical test strip (Rapid ID 32 Staph [bioMérieux, Durham, NC, USA]) (5). As highlighted in Table 1, the PYR activity of S. delphini is listed in some clinical reference texts as “not determined” or “not available,” and in other references either S. delphini or the PYR test result is excluded from Staphylococcus species identification tables (7–10). In comparison, the PYR activities of S. intermedius and S. pseudintermedius are clearly documented as positive (7–9). Furthermore, rather than using multibiochemical test strips, PYR activity is typically evaluated in the routine clinical microbiology setting with rapid PYR disc or slide kits, which can be used in less than 5 min. Therefore, the purpose of this study was to determine the PYR activities of S. delphini strains using the reference standard broth method (3) to complete an important piece of “missing” biochemical data and to evaluate the performance of four rapid PYR test kits produced by different manufacturers to assist clinical microbiologists in the rapid differentiation of S. aureus from the phenotypically similar coagulase-positive SIG members.

View this table:
  • View inline
  • View popup
TABLE 1

Documented PYR activities of S. aureus and members of the S. intermedius group represented in clinical reference texts

RESULTS

Each PYR test kit reacted as expected with the control organisms (Streptococcus agalactiae, negative; Enterococcus faecalis, positive). Only one manufacturer (Key Scientific Products) included expected reactions for Staphylococcus species in its instructions. Nonetheless, the selected S. aureus (negative) and S. pseudintermedius (positive) controls performed consistently with complete agreement for each test kit, at each test point, and, in the case of the rapid PYR disc/slide tests, between laboratories. Positive PYR reactions observed in the reference broth test were indicated with a brilliant red-fuchsia color, while negative reactions were indicated by yellow or weakly orange color (Fig. 1). Positive PYR reactions observed with the rapid disc and rapid slide tests were of a similar red-pink color but were generally weaker than those observed with the reference broth, and in these tests, Staphylococcus species (S. pseudintermedius and S. delphini) produced weaker reactions than the control Enterococcus species. Results of PYR tests for the 21 S. delphini and control strains are summarized in Table 2. Our results show excellent agreement among the test systems (broth, rapid disc, and rapid slide), manufacturers, and laboratories, with all S. delphini strains testing positive for PYR activity except for one strain that tested negative with one rapid disc test kit in one laboratory. Interlaboratory agreement, based on total number of rapid disc and rapid slide tests (42 rapid disc/slide test results in total for both testing sites) performed on all S. delphini strains was 97.6% (41/42 rapid disc/slide test results) (Table 2).

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

Observed broth PYR reactions for the control and S. delphini DSM 20771T strains. 1, Enterococcus faecalis ATCC 29212; 2, Streptococcus agalactiae ATCC 12386; 3, Staphylococcus aureus ATCC 25923; 4, Staphylococcus pseudintermedius LMG 22219T; 5, Staphylococcus delphini DSM 20771T.

View this table:
  • View inline
  • View popup
TABLE 2

Results of PYR broth and rapid PYR disc/slide testing at the two testing sites

DISCUSSION

Of the tested S. delphini isolates in this study, 100% tested positive using the reference PYR broth method, while >95% of the rapid disc/slide test results for the 21 S. delphini isolates were positive. The ability to accurately differentiate Staphylococcus aureus from other phenotypically similar coagulase-positive staphylococci is important for accurate interpretation of antimicrobial susceptibility test results that may influence therapy selection. This has been demonstrated most clearly with respect to the detection of methicillin susceptibility in S. aureus versus S. pseudintermedius (11). While some reference and larger hospital-based microbiology laboratories have turned to DNA sequencing- or mass spectrometry-based technologies to rapidly and accurately identify Staphylococcus species (12–14), many laboratories will continue to utilize single rapid tests and short test sets for the identification of S. aureus and SIG members. The use of PYR testing to distinguish some coagulase-positive Staphylococcus species from S. aureus is well established (7, 8, 9; see also http://www.aavmc.org/data/files/case-study/burnham%20-%20staph%20pseudintermedius%20-%20student%20materials.pdf ). The rapid PYR disc methods took <5 min to complete, while the reference broth method required 4 h. It should be noted that strict adherence to manufacturer recommendations is required for all PYR-based tests. It is especially important that PYR test reactions be read promptly after adding the development reagent (N,N-dimethylaminocinnamaldehyde), since some negative reactions may appear positive after increased time. Yellow-, salmon-, or orange-colored reactions are generally considered by all manufacturers to be negative. It is recommended that isolates exhibiting pale-pink or weak reactions be retested either with a longer substrate incubation of 5 min, directly with reagent alone to determine if the reactions are specific to the development reagent rather than the substrate, or using the reference tube method.

The purpose of this study was to complete “missing” biochemical data for S. delphini to facilitate the rapid differentiation of S. aureus and members of the SIG isolated from animal and human clinical specimens. While S. pseudintermedius is increasingly recognized as a potential human pathogen (11, 15), S. delphini and S. intermedius are primarily animal pathogens. To the best of the authors' knowledge, neither S. delphini nor S. intermedius sensu stricto has been reported as a cause of human infection; likewise, methicillin resistance has not been reported in these species. Each of the S. delphini isolates used in this study was presumed to be susceptible to oxacillin by the standard disk diffusion method (range of zone of inhibition diameters, 22 to 28 mm; arithmetic mean, 26 mm) according to interpretive criteria used for S. pseudintermedius (11), and the mecA gene was not detected by PCR (data not shown). Perhaps due to misidentifications as S. aureus (12, 16) and the lack of routine species differentiation within the SIG in some laboratories, the true epidemiology and distribution of S. delphini infections in the human population may not be known. S. delphini has been isolated from many different animal species (17–19), including some, such as horses, that may have close human contact. Therefore, methods that can be used for quick presumptive recognition of all members of the SIG (including S. delphini), such as PYR, will be very useful in medical and veterinary clinical microbiology laboratories.

MATERIALS AND METHODS

Bacterial strains.We used four control strains: Enterococcus faecalis strain ATCC 29212, Streptococcus agalactiae strain ATCC 12386, Staphylococcus aureus strain ATCC 25923 (American Type Culture Collection, Manassas, VA, USA), and Staphylococcus pseudintermedius strain LMG 22219T (received from Freddy Haesebrouck, Ghent University, Ghent, Belgium). The Staphylococcus delphini strains used in this study are summarized in Table 3. The S. delphini strain collection included seven previously published strains, including the S. delphini type strain (S. delphini DSM 20771T) (received from Vincent Perreten, University of Bern, Bern, Switzerland), and 14 clinical strains identified in this study. All isolates were cultured on tryptic soy agar with 5% sheep blood (TSAB) (Becton, Dickinson and Company, Franklin Lakes, NJ, USA). Initially, isolates (21 test strains and four control strains) were subcultured from long-term stocks and incubated at 35 ± 2°C in 5% carbon dioxide (CO2) for 18 to 24 h. Subsequently, these cultures were subcultured and incubated at 35 ± 2°C in 5% CO2 for 18 to 24 h prior to PYR testing.

View this table:
  • View inline
  • View popup
TABLE 3

Staphylococcus delphini strains used in this study

Molecular identification of Staphylococcus delphini isolates.Bacterial cell lysates were obtained from colonies grown on TSAB following incubation at 35 ± 2°C in 5% CO2 for 18 to 24 h. A single isolated colony was suspended in 0.5 ml of a 1:1 mix (vol/vol) containing Tris-EDTA buffer (10 mM Tris, 1 mM EDTA [pH 8.0]) and 0.1-mm zirconium beads (Biospec Products, Bartlesville, OK, USA) and subsequently vortexed to disrupt bacterial cells. The species and subgroup identification of S. delphini strains were confirmed by thermonuclease (nuc) gene PCR using previously described primers (23). The total reaction mixture for each PCR was 25 μl, containing 2.5 μl of supernatant from the bacterial cell lysate, 1 μl of each primer (final concentration, 10 pmol), 8 μl of water, and 12.5 μl of 2× PCR solution with a final concentration of 0.625 U rTaq polymerase, 0.2 mM deoxynucleoside triphosphate mixture, and 1× reaction buffer (Premix Taq, TaKaRa Bio Inc., Kyoto, Japan). The thermocycler parameters were 1 cycle at 95°C for 1 min 30 s, 30 cycles at 56°C for 30 s, 72°C for 2 min 30 s and 94°C for 1 min, 1 cycle at 50°C for 2 min, and 1 cycle at 72°C for 5 min, followed by holding at 4°C. Resultant PCR products were resolved by agarose gel electrophoresis (1.0%) and visualized by staining with ethidium bromide (0.5 μg/ml).

Antimicrobial susceptibility testing.Each S. delphini isolate was tested for oxacillin susceptibility using the standard disk diffusion method as recommended by the Clinical and Laboratory Standards Institute (CLSI) (24). Diameters of the zone of growth inhibition were recorded and, because no interpretive breakpoints that apply specifically to this species exist, comparisons were made to the current breakpoints used for S. pseudintermedius (11, 24). Bacterial cell lysates, obtained as described above, were subjected to PCR for the mecA gene using previously described primers, thermocycling conditions, and agarose gel electrophoresis method (25).

PYR testing.Four control strains were used to validate products each time S. delphini strains were tested. Reference broth testing was performed using Remel PYR broth (catalog number 062085; Thermo Fisher Scientific [Remel], Lenexa, KS, USA) at one location (University of Tennessee). Each isolate was tested only once, and testing was performed and interpreted by a single individual according to manufacturer instructions. PYR broth was inoculated with 4 colonies from an overnight TSAB plate culture and incubated in an aerobic atmosphere for 4 h at 37°C. After incubation, 1 drop of PYR reagent (catalog number R21258) was added to the tube. A red (positive) color reaction was recorded after 1 min and checked for significant change at 2 min. The following rapid disc or rapid slide tests were tested: manufacturer A, PYR disc with reagent (catalog number R30854301; Thermo Fisher Scientific [Remel]); manufacturer B, BBL DrySlide PYR kit (catalog number 231747; Becton, Dickinson and Company); manufacturer C, PYR test kit and reagent (catalog number Z175; Hardy Diagnostics, Santa Maria, CA, USA); and manufacturer D, PYR discs (with PEP) (catalog number K1538B; Key Scientific Products, Stamford, TX, USA). For the rapid disc or rapid slide tests, testing was conducted independently at two locations (University of Tennessee and Weill Cornell Medical College) using kits from identical lots. At each site, isolates were assayed only once by each of the different disc or slide tests. Furthermore, testing was performed and interpreted by a single individual at each site according to manufacturer instructions. The sites were not blinded to the PYR activity of the control strains for the rapid PYR tests, as this served as quality control prior to testing. However, all other testing factors were blinded. Discs and slides were moistened with a 10-μl loopful of distilled water, the incubation time of the organism on discs and slides for all kits prior to addition of reagent was 2 min (including Key Scientific Products, which indicates that the incubation time can be between 2 and 5 min), and the color reaction was recorded 1 min after addition of the reagent for all kits tested (including Key Scientific Products, which instructs at least 1 min but not more than 2 min before recording).

ACKNOWLEDGMENTS

We thank the representatives of Thermo Fisher Scientific (Remel), Becton, Dickinson and Company, Hardy Diagnostics, and Key Diagnostics for generously providing samples of PYR test products used in this study. We are also grateful to Rupal Brahmbhatt, Mary Jean Bryant, Rebekah Jones, and Brian Johnson for technical assistance, Phil Snow for photographic assistance, and Vincent Perreten and Freddy Haesebrouck for providing reference strains.

S.T.C. was supported by a fellowship from the University of Tennessee College of Veterinary Medicine, Center of Excellence in Livestock Diseases and Human Health, Student Summer Research Program. This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

FOOTNOTES

    • Received 10 October 2016.
    • Returned for modification 1 November 2016.
    • Accepted 19 December 2016.
    • Accepted manuscript posted online 21 December 2016.
  • Copyright © 2017 American Society for Microbiology.

All Rights Reserved .

REFERENCES

  1. 1.↵
    1. Facklam RR,
    2. Thacker LG,
    3. Fox B,
    4. Eriquez L
    . 1982. Presumptive identification of streptococci with a new test system. J Clin Microbiol15:987–990.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Oberhofer TR
    . 1986. Value of the L-pyrrolidonyl-β-napthylamine hydrolysis test for identification of select Gram-positive cocci. Diagn Microbiol Infect Dis4:43–47. doi:10.1016/0732-8893(86)90055-6.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    1. Frank KL,
    2. del Pozo JL,
    3. Patel R
    . 2008. From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis. Clin Microbiol Rev21:111–133. doi:10.1128/CMR.00036-07.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. Devriese LA,
    2. Vancanneyt M,
    3. Baele M,
    4. Vaneechoutte M,
    5. De Graef E,
    6. Snauwaert C,
    7. Cleenwerck I,
    8. Dawyndt P,
    9. Swings J,
    10. Decostere Haesebrouck AF
    . 2005. Staphylococcus pseudintermedius sp. nov., a coagulase positive species from animals. Int J Syst Evol Microbiol55:1569–1573. doi:10.1099/ijs.0.63413-0.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    1. Sasaki T,
    2. Kikuchi K,
    3. Tanaka Y,
    4. Takahashi N,
    5. Kamata S,
    6. Hiramatsu K
    . 2007. Reclassification of phenotypically identified Staphylococcus intermedius strains. J Clin Microbiol45:2770–2778. doi:10.1128/JCM.00360-07.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    1. Varaldo PE,
    2. Kilpper-Balz R,
    3. Biavasco F,
    4. Satta G,
    5. Schleifer KH
    . 1988. Staphylococcus delphini sp nov. a coagulase-positive species isolated from dolphins. Int J Syst Evol Microbiol38:436–439.
    OpenUrlCrossRef
  7. 7.↵
    1. Becker K,
    2. Skov RL,
    3. von Eiff C
    . 2015. Staphylococcus, Micrococcus, and other catalase-positive cocci, p 354–382. InJorgensen JH, Pfaller MA, Carroll KC, Funke G, Landry ML, Richter SS, Warnock DW (ed), Manual of clinical microbiology, 11th ed, vol 1. ASM Press, Washington, DC.
    OpenUrl
  8. 8.↵
    1. Procop GW,
    2. Church DL,
    3. Hall GS,
    4. Janda WM,
    5. Koneman EW,
    6. Schreckenberger PC,
    7. Woods GL
    (ed). 2017. Koneman's color atlas and textbook of diagnostic microbiology, p 670–732, 7th ed. Wolters Kluwer, Philadelphia, PA.
  9. 9.↵
    1. Tille P
    (ed). 2014. Bailey and Scott's diagnostic microbiology, p 232–246, 13th ed. Mosby, St. Louis, MO.
  10. 10.↵
    1. Markey B,
    2. Leonard F,
    3. Archambault M,
    4. Cullinane A,
    5. Maguire D
    . 2013. Clinical veterinary microbiology, p 105–119, 2nd ed. Mosby, St. Louis, MO.
  11. 11.↵
    1. Wu MT,
    2. Burnham C,
    3. Westblade LF,
    4. DienBard J,
    5. Lawhon SD,
    6. Wallace MA,
    7. Stanley T,
    8. Burd E,
    9. Hindler J,
    10. Humphries RM
    . 2016. Evaluation of oxacillin and cefoxitin disk and MIC breakpoints for prediction of methicillin resistance in human and veterinary isolates of Staphylococcus intermedius group. J Clin Microbiol54:535–542. doi:10.1128/JCM.02864-15.
    OpenUrlAbstract/FREE Full Text
  12. 12.↵
    1. Viau R,
    2. Hujer AM,
    3. Hujer KM,
    4. Bonomo RA,
    5. Jump RLP
    . 2015. Are Staphylococcus intermedius infections in humans cases of mistaken identity? A case series and literature review. Open Forum Infect Dis2:ofv110. doi:10.1093/ofid/ofv110.
    OpenUrlCrossRefPubMed
  13. 13.↵
    1. Decristophoris P,
    2. Fasola A,
    3. Benagli C,
    4. Tonolla M,
    5. Petrini O
    . 2011. Identification of Staphylococcus intermedius group by MALDI-TOF MS. Syst Appl Microbiol34:45–51. doi:10.1016/j.syapm.2010.11.004.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.↵
    1. Westblade LF,
    2. van Belkum A,
    3. Grundhoff A,
    4. Weinstock GM,
    5. Palmer EG,
    6. Pallen MJ,
    7. Dunne WM Jr
    . 2016. Role of clinicogenomics in infectious disease diagnostics and public health microbiology. J Clin Microbiol54:1686–1693. doi:10.1128/JCM.02664-15.
    OpenUrlAbstract/FREE Full Text
  15. 15.↵
    1. Frank MG,
    2. Keniston A,
    3. Madinger N,
    4. Price C,
    5. Bessesen MT
    . 2015. Staphylococcus intermedius group infections in humans: report of four cases and a literature review. JMM Case Rep2 doi:10.1099/jmmcr.0.000066.
    OpenUrlCrossRef
  16. 16.↵
    1. Börjesson S,
    2. Gomez-Sanz E,
    3. Ekström K,
    4. Torres C,
    5. Grönlund U
    . 2015. Staphylococcus pseudintermedius can be misdiagnosed as Staphylococcus aureus in humans with dog bite wounds. Eur J Clin Microbiol Infect Dis34:839–844. doi:10.1007/s10096-014-2300-y.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Ben Zakour NL,
    2. Beatson SA,
    3. van den Broek AH,
    4. Thoday KL,
    5. Fitzgerald JR
    . 2012. Comparative genomics of the Staphylococcus intermedius group of animal pathogens. Front Cell Infect Microbiol2:44. doi:10.3389/fcimb.2012.00044.
    OpenUrlCrossRefPubMed
  18. 18.↵
    1. Guardabassi L,
    2. Schmidt KR,
    3. Petersen TS,
    4. Espinosa-Gongora C,
    5. Moodley A,
    6. Agersø Y,
    7. Olsen JE
    . 2012. Mustelidae are natural hosts of Staphylococcus delphini group A. Vet Microbiol159:351–353.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Stull JW,
    2. Slavic D,
    3. Rousseau J,
    4. Weese JS
    . 2014. Staphylococcus delphini and methicillin-resistant S. pseudintermedius in horses, Canada. Emerg Infect Dis20:485–448. doi:10.3201/eid2003.130139.
    OpenUrlCrossRef
  20. 20.
    1. Bannoehr J,
    2. Ben Zakour NL,
    3. Waller AS,
    4. Guardabassi L,
    5. Thoday KL,
    6. van den Brock AHM,
    7. Fitzgerald JR
    . 2007. Population genetic structure of the Staphylococcus intermedius group: insights into agr diversification and the emergence of methicillin-resistant strains. J Bacteriol189:8685–8692. doi:10.1128/JB.01150-07.
    OpenUrlAbstract/FREE Full Text
  21. 21.
    1. Futagawa-Saito K,
    2. Sugiyama T,
    3. Karube S,
    4. Sakurai N,
    5. Ba-Thein W,
    6. Fukuyasu T
    . 2004. Prevalence and characterization of leukotoxin-producing Staphylococcus intermedius in isolates from dogs and pigeons. J Clin Microbiol42:5324–5326. doi:10.1128/JCM.42.11.5324-5326.2004.
    OpenUrlAbstract/FREE Full Text
  22. 22.
    1. Bes M,
    2. Saidi Slim I,
    3. Becharnia F,
    4. Meugnier H,
    5. Vandenesch F,
    6. Etienne J,
    7. Freney J
    . 2002. Population diversity of Staphylococcus intermedius isolates from various host species: typing by 16S-23S intergenic ribosomal DNA spacer polymorphism analysis. J Clin Microbiol40:2275–2277. doi:10.1128/JCM.40.6.2275-2277.2002.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    1. Sasaki T,
    2. Tsubakishita S,
    3. Tanaka Y,
    4. Sakusabe A,
    5. Ohtsuka M,
    6. Hirotaki S,
    7. Kawakami T,
    8. Fukata T,
    9. Hiramatsu K
    . 2010. Multiplex-PCR method for species identification of coagulase-positive staphylococci. J Clin Microbiol48:765–769. doi:10.1128/JCM.01232-09.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    Clinical and Laboratory Standards Institute. 2015. Performance standard for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals (approved standard); 4th edition and supplement. VET01-A4 and VET01S-Ed3. Clinical and Laboratory Standards Institute, Wayne, PA.
  25. 25.↵
    1. Bemis DA,
    2. Jones RD,
    3. Frank LA,
    4. Kania SA
    . 2009. Evaluation of susceptibility test breakpoints used to predict mecA-mediated resistance in Staphylococcus pseudintermedius isolated from dogs. J Vet Diagn Invest21:53–58. doi:10.1177/104063870902100108.
    OpenUrlCrossRefPubMedWeb of Science
PreviousNext
Back to top
Download PDF
Citation Tools
Evaluation of Pyrrolidonyl Arylamidase Activity in Staphylococcus delphini
Samantha T. Compton, Stephen A. Kania, Amy E. Robertson, Sara D. Lawhon, Stephen G. Jenkins, Lars F. Westblade, David A. Bemis
Journal of Clinical Microbiology Feb 2017, 55 (3) 859-864; DOI: 10.1128/JCM.02076-16

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of Pyrrolidonyl Arylamidase Activity in Staphylococcus delphini
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Evaluation of Pyrrolidonyl Arylamidase Activity in Staphylococcus delphini
Samantha T. Compton, Stephen A. Kania, Amy E. Robertson, Sara D. Lawhon, Stephen G. Jenkins, Lars F. Westblade, David A. Bemis
Journal of Clinical Microbiology Feb 2017, 55 (3) 859-864; DOI: 10.1128/JCM.02076-16
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

Aminopeptidases
Staphylococcus
Staphylococcus delphini
Staphylococcus intermedius group
pyrrolidonyl arylamidase

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

 

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X